Myasthenia gravis: vizsgálatok itt: Egyesült Államok
52 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Where
- Atlanta, Augusta, Carlsbad, Chapel Hill, Charleston, Charlottesville, Cincinnati, Clearwater, Dallas, Denton, Denver, Detroit, Durham, East Lansing, Eugene, Fort Collins, Foxborough, Greenfield, Houston, Huntsville, Irvine, Lexington, Los Angeles, Lubbock, Memphis, Miami, Mobile, New Haven, New Orleans, New York, Nicholasville, Oklahoma City, Omaha, Ormond Beach, Phoenix, Port Charlotte, Raleigh, Rancho Mirage, Richmond, Rockledge, San Francisco, Schaumburg, Scottsdale, Tampa, Totowa, Tucson, Washington D.C., Yukon
- Életkor
- 18 év to 80 év
- People
- 231 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07039916 · EU 2024-515979-35-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Where
- Amherst, Cincinnati, Columbus, Greenfield, O'Fallon, Scottsdale
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07463521 · EU 2025-524756-54-00 - 3. fázisTaking peopleA Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Where
- Columbus, Scottsdale
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07465289 · EU 2025-524757-14-00 - 3. fázisTaking peopleA Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Where
- Augusta, Aurora, Boca Raton, Boston, Burlington, Charleston, Cincinnati, Cleveland, Columbus, Cordova, Dallas, Durham, Jacksonville, Kansas City, Los Angeles, New Haven, Palo Alto, Paradise Valley, Pasadena, Port Charlotte, Scottsdale, St Louis, Tampa
- Életkor
- 18 év and over
- People
- 199 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04951622 · EU 2023-504152-97-00 - 2/3. fázisVisszavonvaA Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
- Where
- Chicago, Denton
- Életkor
- 12 év to 17 év
- People
- 8 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT06055959 · EU 2022-502072-23-00 - 2/3. fázisTaking peopleA Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
- Where
- Ann Arbor, Aurora, Hershey, Lawrence, Los Angeles, Palo Alto, Philadelphia, Phoenix, Pittsburgh, San Francisco, Tampa
- Életkor
- 2 év to 17 év
- People
- 12 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05265273 · EU 2022-502539-21-00 - 2. fázisTaking peopleADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- Where
- Amherst, Austin, Carlsbad, Chattanooga, Las Vegas, Miami
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- argenx
See details and how to joinNCT07673627 · EU 2025-522939-33-00 - 2/3. fázisCsak meghívásosEvaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis
- Where
- Charlotte, Charlottesville, Chicago
- Életkor
- 2 év to 18 év
- People
- 12 worldwide
- Run by
- argenx
See details and how to joinNCT05374590 · EU 2023-507379-23-00 - 3. fázisTaking peopleComparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Where
- Austin, Boca Raton, Colorado Springs, Cordova, Dallas, Detroit, East Lansing, Farmington, Fort Collins, Foxborough, Fullerton, Houston, Indianapolis, Kirkland, New Orleans, New York, O'Fallon, Pomona, Raleigh, Winston-Salem
- Életkor
- 18 év to 74 év
- People
- 115 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07217587 · EU 2025-521130-28-00 - 3. fázisTaking peopleA Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Where
- Boca Raton, Fayetteville, Houston, Pasadena
- Életkor
- 18 év to 80 év
- People
- 195 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT07647510 · EU 2026-525298-38-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- Where
- Clearwater, Colorado Springs, Farmington Hills, Greenville, Maitland, New Bern
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- TG Therapeutics, Inc.
See details and how to joinNCT07673744 · EU 2025-524630-26-00 - No phaseTaking peopleRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
- Where
- Sioux Falls
- People
- 20 000
- Run by
- Sanford Health
See details and how to joinNCT01793168 - 1. fázisTaking peopleA Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- Where
- Ann Arbor, Cleveland, Columbus, La Jolla, Milwaukee, New York, Omaha, Rochester
- Életkor
- 18 év and over
- People
- 100
- Run by
- TG Therapeutics, Inc.
See details and how to joinNCT06680037 - No phaseTaking peopleADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Where
- Amherst, Austin, Boston, Carlsbad, Chapel Hill, Chattanooga, Cincinnati, Columbus, Detroit, Durham, Las Vegas, Miami, San Antonio, Tampa
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- argenx
See details and how to joinNCT07294170 - 2. fázisTaking peopleA Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- Where
- Austin, Chicago, Philadelphia, Seattle
- Életkor
- 2 év to 17 év
- People
- 15 worldwide
- Run by
- Amgen
See details and how to joinNCT06987539 · EU 2025-520993-20-00 - 1. fázisTaking peopleStudy of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
- Where
- Columbus, Dallas, Detroit, Houston, Los Angeles, Minneapolis, New York, Orange, Palo Alto, Philadelphia, Portland, Rochester, Tampa
- Életkor
- 18 év and over
- People
- 30
- Run by
- Kite, A Gilead Company
See details and how to joinNCT06626919 - 3. fázisTaking peopleEfficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Where
- Altamonte Springs, Boca Raton, Burlington, Centerville, Chapel Hill, Charleston, Chattanooga, Cincinnati, Dallas, El Paso, Falls Church, Farmington, Greenfield, Jacksonville, Kansas City, Longmont, Maitland, McKinney, Phoenix, Tampa, Washington D.C., Winston-Salem
- Életkor
- 18 év and over
- People
- 264 worldwide
- Run by
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
See details and how to joinNCT06463587 · EU 2023-507746-83-00 - 1/2. fázisTaking peopleRESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Where
- Aurora, Boston, Chicago, Houston, Jacksonville, Kansas City, New York, Orange, Portland, Rochester, Sacramento, San Francisco, Seattle, Worcester
- Életkor
- 18 év to 70 év
- People
- 24
- Run by
- Cabaletta Bio
See details and how to joinNCT06359041 - 1. fázisTaking peopleStudy of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
- Where
- Newport Beach, New York, Palo Alto, Salt Lake City, Seattle
- Életkor
- 18 év to 75 év
- People
- 57 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT07304154 - No phaseNot yet taking people in Egyesült ÁllamokQuantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG
- Where
- Boston
- Életkor
- 18 év to 80 év
- People
- 25
- Run by
- BioSensics
See details and how to joinNCT07226830 - No phaseTaking peopleFeasibility of Remote Monitoring of Patients With Myasthenia Gravis
- Where
- Washington D.C.
- Életkor
- 18 év and over
- People
- 18
- Run by
- George Washington University
See details and how to joinNCT07787247 - 2/3. fázisFut, nem toborozA Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
- Where
- Charlotte, Charlottesville, Denton
- Életkor
- 2 év to 17 év
- People
- 12 worldwide
- Run by
- argenx
See details and how to joinNCT06392386 · EU 2023-506159-12-00 - 2. fázisTaking peopleADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Where
- Amherst, Austin, Boston, Carlsbad, Chapel Hill, Chattanooga, Cincinnati, Columbus, Detroit, Durham, Las Vegas, Miami, San Antonio, Tampa
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- argenx
See details and how to joinNCT07284420 · EU 2025-522492-28-00 - 3. fázisTaking peopleZilucoplan for Severe gMG Exacerbations
- Where
- Columbus, Kansas City, Tampa
- Életkor
- 18 év and over
- People
- 15
- Run by
- Miriam Freimer
See details and how to joinNCT07215949 - No phaseCsak meghívásosPPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry
- Where
- Waltham
- Életkor
- 18 év and over
- People
- 1500
- Run by
- CorEvitas
See details and how to joinNCT07217509